investment
SGS reveals investment into North American biopharmaceutical testing capabilities
Biopharmaceutical analytical and bioanalytical contract solutions provider, SGS, has revealed it is investing more than $1.7 million to expand its North American biopharmaceutical testing capabilities in Illinois. Read more
Citoxlab signs investment and partnership deal with oncology CRO
Contract research organisation (CRO) for non-clinical research, Citoxlab, has signed an investment and partnership deal with Experimental Pharmacology and Oncology Berlin-Buch (EPO). Read more
Azeria Therapeutics successful raises £4 million in investment round
Newly formed drug discovery company, Azeria Therapeutics, has announced that it has successfully raised £4 million in a Series A investment round from the £70 million CRT Pioneer Fund, managed by Sixth Element Capital. Read more
Austrian biotech receives funding to advance therapies to combat antibiotic-resistance
Vienna-based biotech company, PhagoMed Biopharma, has received more than €4 million in grants and private investments, which will be used to boost the development of alternative therapies to combat antibiotic-resistant bacteria. Read more
Biocatalysts celebrates 35th anniversary by investing in future manufacturing capacity
In celebration of its 35th year, speciality enzyme company, Biocatalysts, has made a major investment into its future manufacturing capacity. Read more
Siemens & Bentley Systems further strengthen alliance
Siemens and Bentley Systems have agreed to further strengthen their strategic alliance and joint investment initiatives, increasing the joint innovation investment programme from €50 million to €100 million. Read more
TraceLink closes investment round to accelerate development of digital supply chain
TraceLink has closed an investment round worth $93 million that will be used to speed up the expansion of information sharing network platform across the life sciences. Read more
Ubiquigent receives grant from Innovate UK
Ubiquigent — a company focused on enabling and supporting ubiquitin system targeted drug discovery — has been awarded a new grant from Innovate UK. Read more
Orchard Therapeutics completes Series C financing round
Commercial-stage company — Orchard Therapeutics — has completed its Series C financing round, raising $150 million to be used in the advancement of its gene therapy pipeline. Read more
Artios Pharma completes Series B financing round
DNA Damage Response (DDR) company developing innovative treatments for cancer, Artios Pharma, has announced the completion of its Series B financing round in which it raised $84 million (£65 million). Read more
Manufacturers investing more in the fourth industrial revolution but more progress required, says EEF
A new survey from the manufacturers’ organisation, EEF, has demonstrated that manufacturers are becoming more fluent in their understanding of the fourth industrial revolution with more boosting investments, but further progress is required. Read more
Pfizer to spend nearly half a billion dollars on sterile manufacturing facility
Pfizer — a US based manufacturing and supply company — has announced its $465 million investment to build an advanced sterile injectable pharmaceutical production facility in Portage, Michigan. Read more
Biotech closes financing round worth $2.2 million
Aptamer Group — a biotech business — has closed its Series A financing round, securing $2.2 million from overseas investors to support its aptamer development programme. Read more
Juniper Pharma Services continues strategic capital investment with new processing equipment
Contract development and manufacturing organisation (CDMO), Juniper Pharma Services, has continued its strategic capital investment with the purchase of three additional pieces of processing equipment. Read more
BioAscent Discovery secures £1.6 million in funding for growth
Provider of integrated drug discovery services, BioAscent Discovery, has secured funding worth £1.6 million from Maven Capital Partners, which it will use for growth through its offering of integrated drug discovery and compound management services. Read more
Biopharma company closes an extension of Series B financing round
Biopharmaceutical company, NBE Therapeutics, has closed an extension of its Series B financing round with CHF 20 million investment from Novo Holdings, making it a major shareholder. Read more
Data capture company raises millions in funding
Data capture company, uMotif, has raised £2.4 million in its latest funding round, which was led by Albion Capital — an independent investment manager — along with several angel investors. Read more
PCI installs and validates latest serialisation system in Tredegar facility
PCI Pharma Services has announced the installation and validation of its latest comprehensive serialisation system at its manufacturing Centre of Excellence in Tredegar, UK. Read more
Major new investment set to support the UK in becoming a hub for innovation
A new investment of almost £1 billion into the UK Research and Innovation (UKRI) Future Leaders Fellowship Scheme has been unveiled by business secretary Greg Clark and is anticipated to help make the UK a major hub for research and innovation. Read more
Investment round closes raising $38 million for PatSnap
Provider of research and development (R&D) analytics, PatSnap, has closed its Series D investment round, raising $38 million from three investors and raising the company’s total funding to date to more than $100 million. Read more
